LRRC32 and ovarian cancer: Together with increased TGFB1 secreted by CD73_1 and CD73_2 CAFs, LRRC32 may generate an immune-suppressive and pro-tumorigenic microenvironment to support the malignant phenotype of ovarian cancer cells, as we previously described [23,68].